Showing results (241-250 of 400) with videos related to
Sort By:
Pageof 40
International Journal of Oncology|July 29, 2010
Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivativesGilles Berger, Régis Gasper, Delphine Lamoral-Theys, et al.Biology Direct|January 8, 2015
A new ensemble coevolution system for detecting HIV-1 protein coevolutionGuangdi Li, Kristof Theys, Jens Verheyen, et al.Genome Announcements|August 22, 2015
Complete Genome Sequence of the Nonpathogenic Soil-Dwelling Bacterium Clostridium sporogenes Strain NCIMB 10696Aleksandra M Kubiak, Anja Poehlein, Patrick Budd, et al.Plos One|October 1, 2019
Drivers of HIV-1 transmission: The Portuguese caseAndrea-Clemencia Pineda-Peña, Marta Pingarilho, Guangdi Li, et al.AIDS (London, England)|September 11, 2015
Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individualsRaf Winand, Kristof Theys, Mónica Eusébio, et al.Brain : a Journal of Neurology|May 26, 2024
Localization of stuttering based on causal brain lesionsCatherine Theys, Elina Jaakkola, Tracy R Melzer, et al.Trials|July 31, 2023
Leukocyte- and platelet-rich fibrin in endoscopic endonasal skull base reconstruction: study protocol for a multicenter prospective, parallel-group, single-blinded randomized controlled non-inferiority trialBirgit Coucke, Anaïs Van Hoylandt, Mark Jorissen, et al.Epileptic Disorders : International Epilepsy Journal with Videotape|December 22, 2017
Facing the hidden wall in mesial extratemporal lobe epilepsyTom Theys, Thomas Decramer, Wim Van Paesschen, et al.AIDS Research and Human Retroviruses|December 15, 2015
Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance MutationsKristof Theys, Kristel Van Laethem, Perpetua Gomes, et al.JCO Clinical Cancer Informatics|March 18, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR StudyMatthias Vanderkerken, Koen Van Eygen, Veerle Galle, et al.Pageof 40